Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C 2Carcinoma, Hepatocellular 2Recurrence 1Hepatitis C, Chronic 1Fibrosis 1Diabetes Mellitus 1Cardiovascular Diseases 1

Interventions

Ribavirin 3peginterferon alfa-2a 2sofosbuvir-velpatasvir drug combination 1ledipasvir 1Sofosbuvir 1Introns 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Hepatitis C, Chronic × sofosbuvir-velpatasvir drug combination × Clear all
NCT03520660 2026-06-03

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institutes of Health Clinical Center (CC)

Phase 4 Active not recruiting
121 enrolled
Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡